Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (DBCOND0118156)

Identifiers

Synonyms

Relapsed and/or Refractory Diffuse Large B-cell Lymphoma

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01742988	Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma	Fimepinostat Rituximab Venetoclax	treatment	1	completed